Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

Neurology's 63rd Annual Meeting. Two pivotal Phase 3 studies investigating alemtuzumab, CARE-MS I and II, are currently ongoing. Top-line results from these trials are expected to be available early in the third quarter of 2011 and in the fourth quarter of 2011. The company expects to file for U.S. and EU approval in early 2012, and has been granted fast track status by the FDA.

Genzyme and Isis Pharmaceuticals Inc. announced in April that data from two phase 3 studies of mipomersen in patients who had high cholesterol levels while on lipid-lowering therapy were presented at the American College of Cardiology. In the study in patients with severe heterozygous familial hypercholesterolemia, mipomersen reduced LDL-C, the primary endpoint, by 36% compared with a 13% increase for placebo (p<0.001). Frequently observed adverse events were injection site reactions, flu-like symptoms and elevations in liver transaminases, as seen in previous studies.

Results of a Phase 3 study of mipomersen in patients with high cholesterol at high risk for CHD were also presented in a poster at American College of Cardiology. In this study, mipomersen reduced LDL-C, the primary endpoint, by 37% compared with a 5% reduction for placebo (p<0.001). Genzyme expects to file for EU marketing approval of mipomersen for the treatment of patients with hoFH (homozygous familial hypercholesterolemia) and severe heFH (heterozygous familial hypercholesterolemia) early Q3 2011. Genzyme also expects to file for U.S. approval for the hoFH indication in second half of this year.

In March, sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced results from the Phase III VITAL trial evaluating aflibercept for the second-line treatment of non-small cell lung cancer. The data showed that adding aflibercept to the chemotherapy drug docetaxel did not meet the pre-specified criteria for the primary endpoint of improvement in overall survival compared with a regimen
'/>"/>

SOURCE sanofi-aventis
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Research and Markets ... the "Market Assessment of Respiratory Diagnostics in ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research ... diagnostics market in the United States ... The service provides detailed analysis of the current ...
(Date:5/21/2015)... -- CryoLife, Inc. (NYSE: CRY ), a leading medical ... vascular surgery, announced today that its Board of Directors ... quarter 2015 of $0.03 per share of common stock ... will be paid on June 19, 2015 to all ... The ex-dividend date for the quarterly dividend is June ...
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth # ... Health Record (EHR) is invaluable in any hospital ... are now a requirement and mainstream in healthcare, ... into the EHR is gaining traction in MEDITECH ... Holmes, RN, Site Project Manager & Clinical Analyst ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3
... 2012 Lilly Diabetes today announced a donation of ... The contribution will support the Foundation,s mission to empower ... lives to the fullest. The Foundation will use the ... 1 diabetes as well as conference scholarships for families ...
... April 3, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... District Court for the District of Delaware has ruled ... 7,410,978 (the ,978 Patent), 7,759,359 (the ,359 Patent), 7,781,448 ... (the ,635 Patent) for Sanctura XR® (trospium chloride extended-release ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit 2
(Date:5/22/2015)... 22, 2015 Pro3rd Impression ... exclusively for Final Cut Pro X. Pro3rd Impression's clean ... , Intuitive on-screen-controls allow users to customize scale, ... colors, layouts, and much more can be edited using ... Pro3rd Impression comes packed with 30 simplistically ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... distributor of patented products, launches the Troll Motor Guide, ... convenient way of boating. , "The recreational boating industry ... Scott J. Cooper, CEO and Creative Director of ... water in record numbers and predicts continued steady growth ...
(Date:5/21/2015)... WellCare Health Plans, Inc. (NYSE: WCG) announced ... the Florida Healthy Kids Corporation (FHKC) to continue to provide ... part of the Florida Healthy Kids (FHK) program. Pending execution, ... may be extended for two additional years at FHKC’s discretion. ... the FHK program who live in Regions 1, 2, 3, ...
(Date:5/21/2015)... Baltimore, Md. (PRWEB) May 21, 2015 ... and the University of Maryland, Baltimore Commercial Advisory Board ... (VA) Maryland Health Care System as one of two ... for their ankle robot research, known as Anklebot. ... of Excellence, in collaboration with the University of Maryland ...
(Date:5/21/2015)... ChiliPad is a temperature-regulated ... side of the bed so that users sleep comfortably ... of the bed can pick their ideal sleep temperature ... faster and stay asleep longer. , Unlike other products, ... the temperature which produces a more concentrated temperature than ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:WellCare Selected to Continue Participating in the Florida Healthy Kids Program, Will Serve Nine Florida Regions Under the New Contract 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 2Health News:ChiliPad, a Dual-Zone Temperature-Controlled Mattress Pad, Promotes Better Sleep, Health Benefits, and Saves on Cooling Costs in Upcoming Hot Summer Weather 3
... ... Ken Meares, the Founder and CEO of Great HealthWorks, was recently ... of Broward County,s 2010 Heart Ball - Heart Society. Mr. Meares, company, ... kind, all-natural products, including Omega XL®, which gives consumers the freedom to ...
... - Following strong quarterly results, SXC increases guidance for fiscal, ... SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: ... ended September 30, 2009. Financial references are in U.S. dollars unless ... ------------------, - Revenue was ...
... A national survey of recent hospital patients commissioned by TransUnion ... greater transparency in their hospital bill while only three in ... for charity care programs. , The results of ... of a new healthcare patient payment estimator at the HFMA ...
... ... will donate $3.00 for every diabetes story published on GlucoStories.com , ... Pompano Beach, Fla. (PRWEB) November 5, ... diabetes stories , and announced they will donate $3.00 for every story published ...
... November 11th (11/11) ... Worldwide 11/11 Meditation for the Divine Feminine on November 11 at 11:11pm EST. On ... works for everyone. , ... (PRWEB) November 6, 2009 -- November 11th (11/11) is a portal, a gateway, and a potent ...
... ... HMSA HI-IQ EHR Adoption and Reimbursement Program Helps Fund Ali2i,s Implementation , ... Dallas and ... a leading developer of electronic health record (EHR) and practice management (PM) systems ...
Cached Medicine News:Health News:Great HealthWorks CEO Ken Meares Named To Executive Cabinet Of American Heart Association - Broward County's 2010 Heart Ball Heart Society 2Health News:Great HealthWorks CEO Ken Meares Named To Executive Cabinet Of American Heart Association - Broward County's 2010 Heart Ball Heart Society 3Health News:SXC Health solutions announces record third quarter financial results 2Health News:SXC Health solutions announces record third quarter financial results 3Health News:SXC Health solutions announces record third quarter financial results 4Health News:SXC Health solutions announces record third quarter financial results 5Health News:SXC Health solutions announces record third quarter financial results 6Health News:SXC Health solutions announces record third quarter financial results 7Health News:SXC Health solutions announces record third quarter financial results 8Health News:SXC Health solutions announces record third quarter financial results 9Health News:SXC Health solutions announces record third quarter financial results 10Health News:SXC Health solutions announces record third quarter financial results 11Health News:SXC Health solutions announces record third quarter financial results 12Health News:SXC Health solutions announces record third quarter financial results 13Health News:SXC Health solutions announces record third quarter financial results 14Health News:SXC Health solutions announces record third quarter financial results 15Health News:SXC Health solutions announces record third quarter financial results 16Health News:SXC Health solutions announces record third quarter financial results 17Health News:SXC Health solutions announces record third quarter financial results 18Health News:SXC Health solutions announces record third quarter financial results 19Health News:SXC Health solutions announces record third quarter financial results 20Health News:TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 2Health News:TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 3Health News:TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 4Health News:GlucoStories Donation Campaign Aims to Raise Diabetes Awareness and Money for Diabetes Causes 2Health News:November 11 at 11:11 Join a Worldwide Meditation for the Divine Feminine and Envision a World that Works for All 2Health News:Ali&#8242;i Health Chooses Aprima Medical Software EHR/PM Solution from Local Reseller, Blue Cliff 2Health News:Ali&#8242;i Health Chooses Aprima Medical Software EHR/PM Solution from Local Reseller, Blue Cliff 3Health News:Ali&#8242;i Health Chooses Aprima Medical Software EHR/PM Solution from Local Reseller, Blue Cliff 4
CRP Liquid Conrtols level 3...
Therapeutic Drug Calibrator Series...
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
The AST method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma...
Medicine Products: